The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded Duke University a $766,551 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to develop implementation strategies to optimize the use of anti-obesity medications (AOMs) and maximize their population health benefits. The project, titled "Developing Robust Anti-Obesity Medication Implementation Approaches to Maximize Population Health (The DOMINO Study)", aims to examine barriers and facilitators to AOM use at the patient, provider, health system, and payer levels. The research team will engage stakeholders across multiple health systems to design tailored implementation strategies for improving AOM access and utilization. The study will involve analysis of multi-site patient data, qualitative interviews, and the development of a roadmap for selecting and implementing effective AOM optimization strategies.
The project includes sub-awards to the University of Missouri System and Wake Forest University Health Sciences to support specific research activities. The University of Missouri System will provide input on implementation outcomes, while Wake Forest University Health Sciences will serve as a site principal investigator, overseeing the study process, data collection, and manuscript development at their institution.
Generated 3/4/25, 7:35 AM